Immunome, Inc. (IMNM)
19.94
-0.94
(-4.50%)
USD |
NASDAQ |
May 18, 15:41
Immunome Total Assets (Quarterly) : 619.79M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.397B |
| Scholar Rock Holding Corp. | 535.25M |
| Stoke Therapeutics, Inc. | 443.28M |
| Nurix Therapeutics, Inc. | 636.13M |
| Exelixis, Inc. | 2.594B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.11M |
| Shareholders Equity (Quarterly) | 588.69M |
| Debt to Equity Ratio | 0.0063 |
| Current Ratio | 21.68 |
| Net Debt Paydown Yield | 0.01% |